Cantor Fitzgerald initiated coverage on iBio
$IBIO
Biotechnology: Pharmaceutical Preparations
Health Care
Cantor Fitzgerald initiated coverage of iBio with a rating of Overweight and set a new price target of $3
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/28/2024 | $5.00 | Buy | Chardan Capital Markets |
| 11/29/2021 | $1.50 | Mkt Outperform | JMP Securities |
| 11/29/2021 | $1.50 | Outperform | JMP Securities |